Populational adaptive evolution, chemotherapeutic resistance and multiple anti-cancer therapies

ESAIM: Mathematical Modelling and Numerical Analysis

Volumn 47, Issue 2, 2013, Pages 377-399

  Lorz, Alexander ^a,b   Lorenzi, Tommaso ^c   Hochberg, Michael E ^d,e   Clairambault, Jean ^a,b   Perthame, Benoît ^a,b,f  

^a SORBONNE UNIVERSITÉ   (France)

^b INRIA ROCQUENCOURT   (France)

^c POLITECNICO DI TORINO   (Italy)

^d UNIV MONTPELLIER   (France)

^e SANTA FE INSTITUTE   (United States)

^f INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

Adaptive evolution; Cancer; Drug resistance; Hamilton Jacobi equations; Integro differential equations; Mathematical oncology

Indexed keywords

CHEMOTHERAPY; DRUG DOSAGE; GENES; INTEGRODIFFERENTIAL EQUATIONS; MECHANICS; ONCOLOGY; TUMORS;

ADAPTIVE EVOLUTION; ANTI-CANCER THERAPIES; ANTICANCER TREATMENT; CANCER; CONTINUOUS VARIABLES; DRUG RESISTANCE; HAMILTON - JACOBI EQUATIONS; VISCOSITY SOLUTIONS;

DISEASES;

EID: 84872710104     PISSN: 28227840     EISSN: 28047214     Source Type: Journal    
DOI: 10.1051/m2an/2012031     Document Type: Article

References (49)

1. N. Bacaër and C. Sokhna, A reaction-diffusion system modeling the spread of resistance to an antimalarial drug. Math. Biosci. Eng. 2 (2005) 227-238.
2. G. Barles, Solutions de viscosité et équations de Hamilton-Jacobi. Collec. SMAI, Springer-Verlag, Paris (2002).
3. G. Barles and B. Perthame, Concentrations and constrained Hamilton-Jacobi equations arising in adaptive dynamics, in Recent Developments in Nonlinear Partial Differential Equations, edited by D. Danielli. Contemp. Math. 439 (2007) 57-68.
4. G. Barles, S. Mirrahimi and B. Perthame, Concentration in Lotka-Volterra parabolic or integral equations: a general convergence result. Methods Appl. Anal. 16 (2009) 321-340.
5. G. Bell and S. Collins, Adaptation, extinction and global change. Evolutionary Applications 1 (2008) 3-16.
6. I. Bozic, T. Antal, H. Ohtsuki, H. Carter, D. Kim, S. Chen, R. Karchin, K.W. Kinzler, B. Vogelstein and M.A. Nowak, Accumulation of driver and passenger mutations during tumor progression. Proc. Natl. Acad. Sci. USA 107 (2010) 18545-18550.
7. À. Calsina and S. Cuadrado, A model for the adaptive dynamics of the maturation age. Ecol. Model. 133 (2000) 33-43.
8. À. Calsina and S. Cuadrado, Small mutation rate and evolutionarily stable strategies in infinite dimensional adaptive dynamics. J. Math. Biol. 48 (2004) 135-159. (Pubitemid 40882746)
9. N. Champagnat, R. Ferrière and S. Méléard, Unifying evolutionary dynamics: from individual stochastic processes to macroscopic models. Theor. Popul. Biol. 69 (2006) 297-321.
10. J. Clairambault, Modelling physiological and pharmacological control on cell proliferation to optimise cancer treatments. Math. Model. Nat. Phenom. 4 (2009) 12-67
11. M.G. Crandall, H. Ishii and P.-L. Lions, User's guide to viscosity solutions of second order partial differential equations. Bull. Amer. Math. Soc. 27 (1992) 1-67.
12. E.M.C. D'Agata, M. Dupont-Rouzeyrol, P. Magal, D. Olivier and S. Ruan, The impact of different antibiotic regimens on the emergence of antimicrobial-resistant bacteria. PLoS One 3 (2008) es4036.
13. T. Day and R. Bonduriansky, A unified approach to the evolutionary consequences of genetic and nongenetic inheritance. Amer. Nat. 178 (2011) E18-E36.
14. O. Diekmann, A beginner's guide to adaptive dynamics, in Mathematical modeling of population dynamics, edited by R. Rudnicki. Banach Center Publications 63 (2004) 47-86.
15. O. Diekmann, P.-E. Jabin, S. Mischler and B. Perthame, The dynamics of adaptation: an illuminating example and a Hamilton-Jacobi approach. Theor. Popul. Biol. 67 (2005) 257-271. (Pubitemid 40678713)
16. E.R. Fearon and B. Vogelstein, A genetic model for colorectal tumorigenesis. Cell 61 (1990) 759-767.
17. W.H. Fleming and H.M. Soner, Controlled markov processes and vicosity solutions. Appl. Math. 25 (1993).
18. J. Foo and F. Michor, Evolution of resistance to targeted anti-cancer therapy during continuous and pulsed administration strategies. PLoS Comput. Biol. 5 (2009) e1000557.
19. J. Foo and F. Michor, Evolution of resistance to anti-cancer therapy during general dosing schedules. J. Theor. Biol. 263 (2010) 179-188.
20. E.C. Friedberg, G.C. Walker, W. Siede, R.D. Wood, R.A. Schultz and T. Ellenberger, DNA repair and mutagenesis. ASM Press (2005).
21. R.A. Gatenby, A change of strategy in the war on cancer. Nature 459 (2009) 508-509.
22. R.A. Gatenby, A.S. Silva, R.J. Gillies and B.R. Frieden, Adaptive therapy. Cancer Res. 69 (2009) 4894-4903.
23. J. Goldie and A. Coldman, Drug resistance in cancer: mechanisms and models. Cambridge University Press (1998).
24. R. Gomulkiewicz and R.D. Holt, When does evolution by natural selection prevent extinction ? Evolution 49 (1995) 201-207.
25. M.M. Gottesman, T. Fojo and S.E. Bates, Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2 (2002) 48-58. (Pubitemid 37328807)
26. M. Greaves and C.C. Maley, Clonal evolution in cancer. Nature 481 (2012) 306-313.
27. P.-E. Jabin and G. Raoul, Selection dynamics with competition. J. Math. Biol. 63 (2011) 493-517.
28. C.A. Jerez, Metal Extraction and Biomining, The Desk Encyclopedia of Microbiology, edited by M. Schaechter. Elsevier, Oxford 762-775.
29. M. Kimmel and A. Świerniak, Control theory approach to cancer chemotherapy: benefiting from phase dependence and overcoming drug resistance, in Tutorials in Mathematical Biosciences III, edited by A. Friedman. Lect. Notes Math. 1872 (2006) 185-221.
30. M. Kivisaar, Stationary phase mutagenesis: mechanisms that accelerate adaptation of microbial populations under environmental stress. Environ. Microbiol. 5 (2003) 814-827. (Pubitemid 37181552)
31. N.L. Komarova and D. Wodarz, Drug resistance in cancer: principles of emergence and prevention. Proc. Natl. Amer. Soc. 102 (2005) 9714-9719. (Pubitemid 40981746)
32. V. Lemesle, L. Mailleret and M. Vaissayre, Role of spatial and temporal refuges in the evolution of pest resistance to toxic crops. Acta Biotheor. 58 (2010) 89-102.
33. A. Lorz, S. Mirrahimi and B. Perthame, Dirac mass dynamics in multidimensional nonlocal parabolic equations. CPDE 36 (2011) 1071-1098.
34. P. Magal and Webb G.F. Mutation, selection and recombination in a model of phenotype evolution. Discrete Contin. Dyn. Syst. 6 (2000) 221-236.
35. C. Marzac et al., ATP-Binding-Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients. Haematologica 96 (2011) 1293-1301.
36. F. McCormick, Cancer therapy based on oncogene addiction. J. Surg. Oncol. 103 (2011) 464-467.
37. J. Pasquier, P. Magal, C. Boulangé-Lecomte, G.F. Webb and F. Le Foll, Consequences of cell-to-cell P-glycoprotein transfer on acquired multi-drug resistance in breast cancer: a cell population dynamics model. Biol. Direct 6 (2011) 5.
38. B. Perthame, Transport equations in biology. Series in Frontiers in Mathematics. Birkhauser (2007).
39. B. Perthame and G. Barles, Dirac concentrations in Lotka-Volterra parabolic PDEs. Indiana Univ. Math. J. 57 (2008) 3275-3301.
40. K.J. Pienta, N. McGregor, R. Axelrod and D.E. Axelrod, Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Transl. Oncol. 1 (2008) 158-164.
41. A. Rafii, P. Mirshahi, M. Poupot, A.M. Faussat, A. Simon, E. Ducros, E. Mery, B. Couderc, R. Lis, J. Capdet, J. Bergalet, D. Querleu, F. Dagonnet, J.J. Fournié, J.P. Marie, E. Pujade-Lauraine, G. Favre, J. Soria and M. Mirshahi, Oncologic trogocytosis of an original stromal cells induces chemoresistance of ovarian tumours. PLoS One 3 (2008) e3894.
42. K.W. Scotto, Transcriptional regulation of ABC drug transporters. Oncogene 22 (2003) 7496-7511. (Pubitemid 37487172)
43. N.P. Shah, C.T. Tran, F.Y. Lee, P. Chan, D. Norris and C.L. Sawyers, Overriding imatinib resistance with a novel ABL kinase inhibitor. Sci. Rep. 305 (2004) 399-401. (Pubitemid 38938156)
44. A.S. Silva and R.A. Gatenby, A theoretical quantitative model for evolution of cancer chemotherapy resistance. Biol. Direct 5 (2010) 25.
45. K. Sprouffske, J.W. Pepper and C.C. Maley, Accurate reconstruction of the temporal order of mutations in neoplastic progression. Cancer Prevention Res. 4 (2011) 1135-1144.
46. A.G. Terry and S.A. Gourley, Perverse consequences of infrequently culling a pest. Bull. Math. Biol. 72 (2010) 1666-1695.
47. Tomasetti C. and Levy D. An elementary approach to modeling drug resistance in cancer. Math. Biosci. Eng. 7 (2010) 905-918.
48. C. Tomasetti and D. Levy, Drug resistance always depends on the cancer turnover rate, SBEC, in IFMBE Proc., edited by K.E. Herold, J. Vossoughi and W.E. Bentley. Springer, Berlin 32 (2010) 552-555.
49. D.C. Zhou, S. Ramond, F. Viguié, A.-M. Faussat, R. Zittoun and J.-P. Marie, Sequential emergence of mrp and mdr-1 gene overexpression as well as mdr1-gene translocation in homoharringtonine selected K562 human leukemia cell lines. Int. J. Cancer 65 (1996) 365-371.